Vertex Pharmaceuticals (VRTX)

Depreciation & Amortization

$56.50M

Quarterly · Period ending: · USD

VRTX logo

VRTX Depreciation & Amortization

Latest reported$56.50M
VRTX Quarterly Depreciation & Amortization ($400.00K → $56.50M)
High-resolution chart · PNG

VRTX depreciation & amortization history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Depreciation & Amortization — Quarterly (USD)
Period endingDepreciation & Amortization (USD)
56,500,000
55,900,000
55,700,000
54,000,000
51,700,000
48,400,000
46,500,000
53,200,000
54,000,000
53,500,000
59,000,000
42,100,000
41,400,000
38,800,000
38,400,000
36,700,000
37,300,000
35,900,000
33,832,000
31,696,000
31,300,000
28,834,000
29,355,000
26,642,000
26,697,000
26,821,000
26,256,000
25,847,000
27,698,000
27,140,000
18,826,000
19,192,000
18,059,000
16,343,000
16,432,000
15,225,000
14,890,000
14,850,000
15,451,000
14,569,000
14,963,000
16,415,000
15,747,000
16,168,000
14,065,000
16,363,000
16,336,000
16,961,000
14,172,000
15,788,000
17,631,000
9,489,000
10,554,000
10,691,000
12,373,000
8,593,000
8,665,000
8,560,000
9,724,000
7,750,000
8,709,000
8,858,000
8,205,000
6,758,000
7,912,000
7,584,000
8,383,000
6,815,000
7,745,000
7,164,000
8,575,000
7,953,000
8,170,000
7,498,000
7,451,000
6,835,000
6,852,000
6,321,000
6,875,000
5,934,000
6,809,000
6,250,000
6,889,000
7,029,000
6,531,000
6,840,000
8,023,000
7,208,000
7,284,000
7,125,000
5,821,000
2,906,000
7,462,000
7,249,000
7,297,000
6,572,000
6,281,000
5,282,000
5,724,000
6,658,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.